Surgery Partners Inc
NASDAQ:SGRY

Watchlist Manager
Surgery Partners Inc Logo
Surgery Partners Inc
NASDAQ:SGRY
Watchlist
Price: 21.48 USD -1.65% Market Closed
Market Cap: 2.7B USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
+3%
Revenue
Forecast
+13%
Operating Income
Forecast
+21%
Net Income
Forecast
+22%

Wall Street
Price Targets

SGRY Price Targets Summary
Surgery Partners Inc

Wall Street analysts forecast SGRY stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SGRY is 32.42 USD with a low forecast of 25.25 USD and a high forecast of 37.8 USD.

SGRY Lowest Forecast
Wall Street Target
25.25 USD
18% Upside
SGRY Average Forecast
Wall Street Target
32.42 USD
51% Upside
SGRY Highest Forecast
Wall Street Target
37.8 USD
76% Upside
Lowest
Price Target
25.25 USD
18% Upside
Average
Price Target
32.42 USD
51% Upside
Highest
Price Target
37.8 USD
76% Upside
Surgery Partners Inc Competitors:
Price Targets
CVSG
CVS Group PLC
46% Upside
A
4007
Al Hammadi Holding Co
11% Upside
GHC
Garofalo Health Care SpA
28% Upside
D
4017
Dr Soliman Abdel Kader Fakeeh Hospital Company SCJSC
4% Upside
CVSG
CVS Group PLC
46% Upside
A
4007
Al Hammadi Holding Co
11% Upside
GHC
Garofalo Health Care SpA
28% Upside
D
4017
Dr Soliman Abdel Kader Fakeeh Hospital Company SCJSC
4% Upside
C
CHG
Chularat Hospital PCL
59% Upside
4013
Dr Sulaiman Al-Habib Medical Services Group Co
11% Upside
V
VIBHA
Vibhavadi Medical Center PCL
40% Upside

Revenue
Forecast

Revenue Estimate
Surgery Partners Inc

For the last 8 years the compound annual growth rate for Surgery Partners Inc's revenue is 13%. The projected CAGR for the next 3 years is 10%.

13%
Past Growth
10%
Estimated Growth
Estimates Accuracy
-2%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Surgery Partners Inc

For the last 8 years the compound annual growth rate for Surgery Partners Inc's operating income is 11%. The projected CAGR for the next 3 years is 4%.

11%
Past Growth
4%
Estimated Growth
Estimates Accuracy
-4%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Surgery Partners Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Miss
What are analyst estimates?

See Also

Summary
SGRY intrinsic value, competitors valuation, and company profile.
DCF Valuation
SGRY stock valuation using Discount Cash Flow valuation method.
Relative Valuation
SGRY stock valuation using valuation multiples.
Wall Street Estimates
SGRY price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
SGRY stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is SGRY's stock price target?
Price Target
32.42 USD

According to Wall Street analysts, the average 1-year price target for SGRY is 32.42 USD with a low forecast of 25.25 USD and a high forecast of 37.8 USD.

What is Surgery Partners Inc's Revenue forecast?
Projected CAGR
10%

For the last 8 years the compound annual growth rate for Surgery Partners Inc's revenue is 13%. The projected CAGR for the next 3 years is 10%.

What is Surgery Partners Inc's Operating Income forecast?
Projected CAGR
4%

For the last 8 years the compound annual growth rate for Surgery Partners Inc's operating income is 11%. The projected CAGR for the next 3 years is 4%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 249,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.